Applied Psychophysiology and Biofeedback

, Volume 30, Issue 4, pp 365–373 | Cite as

Neurofeedback: An Alternative and Efficacious Treatment for Attention Deficit Hyperactivity Disorder

  • Daniel J. Fox
  • David F. Tharp
  • Lydia C. Fox


Current research has shown that neurofeedback, or EEG biofeedback as it is sometimes called, is a viable alternative treatment for Attention Deficit Hyperactivity Disorder (ADHD). The aim of this article is to illustrate current treatment modalities(s), compare them to neurofeedback, and present the benefits of utilizing this method of treatment to control and potentially alleviate the symptoms of ADHD. In addition, this article examines the prevalence rates and possible etiology of ADHD, the factors associated with ADHD and brain dysfunction, the current pharmacological treatments of ADHD, Ritalin, and the potential risks and side effects. Behavior modification and cognitive behavioral treatment for ADHD is discussed as well. Lastly, a brief history of the study of neurofeedback, treatment successes and clinical benefits, comparisons to medication, and limitations are presented.


neurofeedback attention deficit hyperactivity disorder ADHD EEG biofeedback ritalin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ackerman, P., Dykman, R., Oglesby, D., & Newton, J. (1994). EEG power spectra of children with dyslexia, slow learners, and normally reading children with ADD during verbal processing. Journal of Learning Disabilities, 27, 619–630.PubMedCrossRefGoogle Scholar
  2. Ackerman, P., Dykman, R., Oglesby, D., & Newton, J. (1995). EEG power spectra of dysphonetic and nondysphonetic poor readers. Brain Language, 49, 140–152.Google Scholar
  3. Amen, D. G., Paldi, J. H., & Thisted, R. A. (1993). Evaluating ADHD with brain SPECT imaging. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1080–1081.PubMedGoogle Scholar
  4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.Google Scholar
  5. Barabasz, M. (1987). Tricotillomania: A new treatment. International Journal of Clinical and Experimental Hypnosis, 35, 146–154.PubMedGoogle Scholar
  6. Barkley, R. A. (1990). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guildford.Google Scholar
  7. Barkley, R. A. (1998). Attention-deficit hyperactivity disorder: A handbook of diagnosis and treatment (2nd ed.). New York: Guilford.Google Scholar
  8. Bellak, L., & Black, R. (1992). Attention-deficit hyperactive disorder in adults. Clinical Therapeutics, 14, 138–147.PubMedGoogle Scholar
  9. Bennett, F. C., Brown, R. T., Craver, J., & Anderson, D. (1999). Stimulant medication for the child with attention-deficit/hyperactivity disorder. Pediatric Clinics of North America, 46, 929–943.PubMedGoogle Scholar
  10. Bradley, C. (1937). The behavior of children receiving benzotropine. American Journal of Psychiatry, 94, 577–585.Google Scholar
  11. Brown, R. T., & Sawyer, M. (1988). Medication for school-aged children: Effects on learning and behavior. New York: Guilford.Google Scholar
  12. Brownell, M., & Yogendran, M. (2001). Attention deficit hyperactivity disorder in Manitoba children: Medical diagnosis and psychostimulant treatment rates. Canadian Journal of Psychiatry, 6, 264–272.Google Scholar
  13. Cantwell, D. (1996). Attention deficit disorder: A review of the past 10 years. Journal of American Academy of Child and Adolescent Psychiatry, 35, 978–987.Google Scholar
  14. Chabot, R. A., Merkin, H., Wood, L. M., Davenport, T. L., & Serfontein, G. (1996). Sensitivity and specificity of QEEG in children with attention deficit or specific developmental learning disorders. Clinical Electroencephalography, 27, 26–34.PubMedGoogle Scholar
  15. Chabot, R. A., & Serfontein, G. (1996). Quantitative electroencephalographic profiles of children with attention deficit disorder. Biological Psychiatry, 40, 951–963.PubMedCrossRefGoogle Scholar
  16. Chartier, G., & Kelly, N. (1991, August). Neurofeedback treatment of attention deficit-hyperactivity disorder. Grand Rounds Presentation, Rex Hospital, Raleigh, NC.Google Scholar
  17. Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (1998). EEG analysis in Attention-Deficit/Hyperactivity Disorder: A comparative study of two subtypes. Psychiatry Research, 81(1), 19–29.PubMedCrossRefGoogle Scholar
  18. Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2001a). Age and sex effects in the EEG: Differences in two subtypes of attention-deficit/hyperactivity disorder. Clinical Neurophysiology, 112(5), 815–826,Google Scholar
  19. Clarke, A. R., Barry, R. J., McCarthy, R., Selikowitz, M., & Brown, C. R. (2002b). EEG differences in two subtypes of attention-deficit/hyperactivity disorder. Psychophysiology, 38(2), 212–221.Google Scholar
  20. Clarke, A. R., Barry, R. J., McCarthy, R., Selikowitz, M., & Brown, C. R. (2002). EEG evidence for a new conceptualisation of attention deficit hyperactivity disorder. Clinical Neurophysiology, 113(7) 1036–1044.PubMedCrossRefGoogle Scholar
  21. Conte, R. (1991). Attention disorders. In B. Wong (Ed.), Learning about learning disabilities. New York: Academic Press.Google Scholar
  22. David, O. (1974). Association between lower lead concentrations and hyperactivity in children. Environmental Health Perspectives, 7, 17–25.PubMedGoogle Scholar
  23. Elia, J., Ambrosini, P. J., & Rapoport, J. L. (1999). Treatment of attention-deficit-hyperactivity disorder. New England Journal of Medicine, 340, 780–788.PubMedCrossRefGoogle Scholar
  24. Feingold, B. (1973). Food additives and child development. Hospital Practice, 8, 11–21.Google Scholar
  25. Feingold, B. (1975). Why your child is hyperactive. New York: Random House.Google Scholar
  26. Firestone, P., Kelly, M. J., Goodman, J. T., & Davey, J. (1981). Differential aspects of parent training and stimulant medication with hyperactives. Journal of the American Academy of Child Psychiatry, 20 135–147.PubMedCrossRefGoogle Scholar
  27. Fuchs, D., Mock, D., Morgan, P. L., & Young, C. L. (2003). Responsiveness-to-intervention: Definitions, evidence, and implications for the learning disabilities construct. Learning Disabilities Research & Practice, 18, 157–172.Google Scholar
  28. Gaddes, W. H., & Edgell, D. (1994). Learning disabilities and brain function. New York: Springer-Verlag.Google Scholar
  29. Goldstein, S., & Goldstein, M. (1990). Managing attention disorders in children: A guide for practitioners. New York: Wiley.Google Scholar
  30. Hynd, G. W. Hem, K. L., Voeller, K. K., & Marshall, R. M. (1991). Neurobiological basis of attention-deficit hyperactivity disorder (ADHD). School Psychological Review 20, 174–186.Google Scholar
  31. Linden, M., Habib, T., & Radojevic, J. (1996). A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities. Biofeedback and Self Regulation, 2, 35–49.Google Scholar
  32. Lubar, J. F. (1991). Discourse on the development of EEG diagnostics and biofeedback for attention-deficit/hyperactivity disorders. Biofeedback and Self-Regulation, 16, 201–224.PubMedGoogle Scholar
  33. Lubar, J. F. (1995). Neurofeedback for the management of attention-deficit/hyperactivity disorder. In M. S. Schwartz & Associates (Eds.), Biofeedback: A practitioner's guide (2nd ed., pp. 493–522). New York: Guildford Press.Google Scholar
  34. Lubar, J. F., & Shouse, M. N. (1976). EEG and behavioral changes in a hyperkinetic child concurrent with training of the sensorimotor rhythm (SMR): A preliminary report. Biofeedback and Self-Regulation, 3, 293–306.Google Scholar
  35. Mann, C. A., Lubar, J. F., Zimmerman, A. W., Miller, C. A., & Muenchen, R. A. (1992). Quantitative analysis of EEG in boys with attention deficit hyperactivity disorder: Controlled study with clinical implications. Pediatric Neurology, 8, 30–36.PubMedCrossRefGoogle Scholar
  36. Marshall, P. (1989). Attention deficit disorder and allergy: A neurochemical model of the relation between the illness. Psychological Bulletin, 106, 434–446.PubMedCrossRefGoogle Scholar
  37. McCarney, S. B. (1995). Attention Deficit Disorders Evaluation Scale. Columbia, MO: Hawthorne Press.Google Scholar
  38. Monastra, V. J., Monastra, D. M., & George, S. (2002). The effects of stimulant therapy, EEG biofeedback, and parenting style on the primary symptoms of attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback, 27, 231–249.PubMedCrossRefGoogle Scholar
  39. National Institute of Health. (1998). Consensus statement on the diagnosis and treatment of attention-deficit/hyperactivity disorder. Bethesda, MD: Author.Google Scholar
  40. Rossieter, T. R., & LaVaque, T. J. (1995). A comparison of EEG biofeedback and psychostimulants in treating attention deficit/hyperactivity disorders. Journal of Neurotherapy, 1, 48–59.Google Scholar
  41. Satterfield, J., Cantwell, D., Lesser, M., & Podosin, R. (1972). Physiological studies of the hyperkinetic kid. American Journal of Psychiatry, 128, 103–108.Google Scholar
  42. Solanto, M. V. (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behavioral Brain Research, 94(1), 127–152.CrossRefGoogle Scholar
  43. Spencer, T., Biederman, J., & Wilens, T. (1999). Attention-deficit/hyperactivity disorder and comorbidity. Pediatric Clinics of North America, 46, 915–944.PubMedCrossRefGoogle Scholar
  44. Swanson, J., McBurnett, T., Wigal, T., Pfiffner, L., Lerner, M., Williams, L., et al. (1993). Effect of stimulant medication on children with attention deficit disorder: A “review of reviews.” Exceptional Children, 60, 154–162.Google Scholar
  45. Tansey, M. A. (1993). Ten-year stability of EEG biofeedback results for a hyperactive boy who failed fourth grade perceptually impaired class. Biofeedback and Self Regulation, 18, 33–44.PubMedGoogle Scholar
  46. The MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073–1086.Google Scholar
  47. Thompson, L., & Thompson, M. (1998). Neurofeedback combined with training in metacognitive strategies: Effectiveness in students with ADD. Applied Psychophysiology and Biofeedback, 23(4), 243–2463.Google Scholar
  48. Volkow, N. D., Wang, G. J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., et al. (2001). Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Journal of Neuroscience, 21, 1–5.Google Scholar
  49. Weiss, G., & Hechtnian, L. T. (1993). Hyperactive children grown up: ADHD in children, adolescents, and adults (2nd ed.). New York: Guilford.Google Scholar
  50. Whalen, C. K., & Henker, B. (1991). Therapies for hyperactive children: Comparisons, combinations, and compromises. Journal of Consulting and Clinical Psychology, 59, 126–137.PubMedGoogle Scholar
  51. Zametkin, A. J., & Rapoport, J. L. (1987). Noradrenergic hypothesis of attention-deficit disorder with hyperactivity: A critical review. In H. V. Metsler (Ed.), Psychopharmacology: The third generation of progress (pp. 837–842). New York: Raven Press.Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Daniel J. Fox
    • 1
    • 3
  • David F. Tharp
    • 1
  • Lydia C. Fox
    • 2
  1. 1.Advanced Neurotherapy Solutions
  2. 2.Sam Houston State UniversityHuntsville
  3. 3.Advanced Neurotherapy Solutions

Personalised recommendations